Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly

NCT00772889 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

971

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza vaccine GSK2186877A
BIOLOGICAL: GSK Biologicals' Fluarix™

Sponsor

GlaxoSmithKline